COPENHAGEN, Denmark, Feb. 8, 2011 (GLOBE NEWSWIRE) -- Exiqon A/S (Copenhagen:EXQ) today announced that data from its diagnostic program on early detection of colorectal cancer in plasma has been selected for oral presentation at the 102nd Annual American Association for Cancer Research (AACR) Meeting to be held 2-6 April in Orlando, Florida.
